Therapeutic effects of four strains of probiotics on experimental colitis in mice

被引:52
作者
Chen, Lin-Lin [1 ]
Wang, Xue-Hong [1 ]
Cui, Yi [1 ]
Lian, Guang-Hui [2 ]
Zhang, Jie [1 ]
Ouyang, Chun-Hui [1 ]
Lu, Fang-Gen [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha 410011, Hunan, Peoples R China
[2] Zhongshan City Peoples Hosp, Dept Gastroenterol, Zhongshan 528400, Guangdong, Peoples R China
关键词
Probiotic; E; faecalis; Experimental colitis; Interleukin-1; Interleukin-4; INFLAMMATORY-BOWEL-DISEASE; LACTOBACILLUS-CASEI; ULCERATIVE-COLITIS; NISSLE-1917; MIXTURE; INFLIXIMAB; REMISSION;
D O I
10.3748/wjg.15.321
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the therapeutic effects of four strains of probiotics (E. feacalis, L. acidophilus, C butyricum and B. adolescentis) on dextran sulphate sodium (DSS)-induced experimental colitis in Balb/c mice. METHODS: Eighty Balb/c mice were randomly divided into 8 groups. Weight-loss, fecal character, fecal occult blood and hematochezia were recorded daily. Disease activity index (DAI) scores were also evaluated everyday. Length of colon was measured and histological scores were evaluated on the 13th day. Myeloperoxidase (MPO) activity was detected. Interleukin-1 (IL-1) and IL-4 expression was detected by ELISA and RT-PCR. RESULTS: The four strains of probiotics relieved the inflammatory condition of DSS-induced experimental colitis in mice. Weight loss was slowed down in all probiotics-treated mice. Even weight gain was observed by the end of probiotics treatment. The DAI and histological scores of probiotics-treated mice were lower than those of mice in the control group (1.9 +/- 0.2 vs 8.6 +/- 0.4, P < 0.05 for E. faecalis). The length of colon of probiotics-treated mice was longer than that of mice in the control group (10.3 +/- 0.34 vs 8.65 +/- 0.77, P < 0.05 for E faecalis). The four strains of probiotics decreased the MP activity and the IL-1 expression, but increased the IL-4 expression. E faecalis had a better effect on DSS-induced experimental colitis in mice than the other three strains. CONCLUSION: The four strains of probiotics have beneficial effects on experimental colitis in mice. E. faecalis has a better effect on DSS-incluced experimental colitis in mice than the other three strains. Supplement of probiotics provides a new therapy for UC. (C) 2009 The WJG Press and Baishideng. All rights reserved.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 26 条
[1]  
Ashwood P, 2004, INFLAMM RES, V53, P53, DOI 10.1007/s00011-003-1219-z
[2]   Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice [J].
Balish, E ;
Warner, T .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2253-2257
[3]   VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[4]   Spontaneous secretion of interferon γ and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes [J].
Carol, M ;
Lambrechts, A ;
Van Gossum, A ;
Libin, M ;
Goldman, M ;
Mascart-Lemone, F .
GUT, 1998, 42 (05) :643-649
[5]   Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases [J].
Chapman, Therese M. ;
Plosker, Greg L. ;
Figgitt, David P. .
BIODRUGS, 2007, 21 (01) :61-63
[6]   VSL#3 probiotic mixture - A review of its use in chronic inflammatory bowel diseases [J].
Chapman, Therese M. ;
Plosker, Greg L. ;
Figgitt, David P. .
DRUGS, 2006, 66 (10) :1371-1387
[7]   Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment [J].
Dieleman, LA ;
Goerres, MS ;
Arends, A ;
Sprengers, D ;
Torrice, C ;
Hoentjen, F ;
Grenther, WB ;
Sartor, RB .
GUT, 2003, 52 (03) :370-376
[8]  
Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
[9]   THE EFFECT OF EXOGENOUS ADMINISTRATION OF LACTOBACILLUS-REUTERI R2LC AND OAT FIBER ON ACETIC ACID-INDUCED COLITIS IN THE RAT [J].
FABIA, R ;
ARRAJAB, A ;
JOHANSSON, ML ;
WILLEN, R ;
ANDERSSON, R ;
MOLIN, G ;
BENGMARK, S .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (02) :155-162
[10]   Probiotics and the management of inflammatory bowel disease [J].
Fedorak, RN ;
Madsen, KL .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) :286-299